PRJNA665621
Treatment with CDK12 inhibitor
HeLa cells were treated with CDK12/13 inhibitor THZ531. The cells are genetically engineered to harbor an artificial factor 9 locus on chromosome 5. RNA sequencing was performed to assess transcriptinal and RNA processing phenotypes after treatment.